Covered recipient · General Payments record
NORMA IGLESIAS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,781.10
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,036.07 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $475.03 | 7 |
| Novo Nordisk AS | $294.65 | 6 |
| Amgen Inc. | $62.22 | 4 |
| Inspire Medical Systems, Inc. | $46.06 | 2 |
| Phadia US Inc. | $35.97 | 1 |
| Exact Sciences Corporation | $22.59 | 1 |
| ABBVIE INC. | $21.57 | 1 |
| Acerta Pharma LLC | $21.30 | 1 |
| Lilly USA, LLC | $21.28 | 1 |
| PFIZER INC. | $17.96 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.57 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964279 | CMS |
| Amgen Inc. | $16.51 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585423 | CMS |
| Amgen Inc. | $14.69 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585425 | CMS |
| Amgen Inc. | $15.96 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585427 | CMS |
| Amgen Inc. | $15.06 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117585429 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.30 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104262551 | CMS |
| Exact Sciences Corporation | $22.59 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114712844 | CMS |
| Inspire Medical Systems, Inc. | $24.31 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148061611 | CMS |
| Inspire Medical Systems, Inc. | $21.75 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148061613 | CMS |
| Lilly USA, LLC | $21.28 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135246887 | CMS |
| Nevro Corp. | $18.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760095 | CMS |
| Nevro Corp. | $20.00 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760101 | CMS |
| Nevro Corp. | $18.18 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760097 | CMS |
| Nevro Corp. | $17.88 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760205 | CMS |
| Nevro Corp. | $128.96 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760207 | CMS |
| Nevro Corp. | $122.79 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760099 | CMS |
| Nevro Corp. | $148.66 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760103 | CMS |
| Novo Nordisk Inc | $21.04 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097675198 | CMS |
| Novo Nordisk Inc | $18.56 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096672184 | CMS |
| Novo Nordisk Inc | $99.95 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097237847 | CMS |
| Novo Nordisk Inc | $11.89 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096779207 | CMS |
| Novo Nordisk Inc | $124.99 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097249970 | CMS |
| Novo Nordisk Inc | $18.22 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096955922 | CMS |
| PFIZER INC. | $17.96 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131040289 | CMS |
| Phadia US Inc. | $35.97 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067584500 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.44 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137583511 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.